Dexco revenue and financials
R$6.86Change from previous close: +0.73%Absolute change: +R$0.05
In the fiscal year ended December 2025, Dexco reported revenue of R$8.25B (+0.17% year over year). Net income was R$1.18M, a net margin of 0.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.17%
- 2025 vs 2024
- Net income growth
- −99.31%
- 2025 vs 2024
- Net margin
- 0.0%
- 2024: 2.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 851 | 1,284 | 1,346 | 794 | 1,708 |
| Depreciation and amortization | 1,226 | 1,199 | 1,166 | 845 | 712 |
| Capital expenditure | -911 | -1,329 | -1,169 | -1,148 | -797 |
| Investing cash flow | -770 | -1,981 | -1,303 | -1,638 | -1,069 |
| Financing cash flow | 859 | -883 | 960 | 1,227 | -942 |
| Dividends paid | -45.5 | -234 | -249 | -0.1 | -1,394 |
| Share repurchases | — | 0.0 | 0.0 | -275 | -89.0 |
| Debt issued | 3,441 | 413 | 2,455 | 2,500 | — |
| Debt repaid | -2,530 | -1,121 | -1,124 | -914 | — |
| Effect of exchange rates | 7.4 | 25.3 | 10.3 | -31.3 | -4.3 |
| Net change in cash | 947 | -1,554 | 1,014 | 350 | -307 |
| Free cash flow | -60.3 | -44.9 | 177 | -354 | 911 |
| Levered free cash flow | -351 | -630 | -309 | -783 | 740 |